RPg Family Wealth Advisory’s AbbVie ABBV Stock Holding History

RPg Family Wealth Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-134	Closed	-$21.7K	–	83
2022 Q1	$21.7K	Hold	134	–	–	0.01%	207
2021 Q4	$18.1K	Hold	134	–	–	0.01%	229
2021 Q3	$14.5K	Hold	134	–	–	0.01%	253
2021 Q2	$15.1K	Buy	+134	New	+$15.1K	0.01%	249
2020 Q4	$14.4K	Hold	134	–	–	0.01%	260
2020 Q3	$11.7K	Hold	134	–	–	0.01%	265
2020 Q2	$13.2K	Buy	+134	New	+$11.8K	0.01%	255
2019 Q2	–	Sell	-350	Closed	-$28.2K	–	279
2019 Q1	$28.2K	Buy	+350	New	+$28.6K	0.02%	203
2018 Q2	–	Sell	-302	Closed	-$28.6K	–	229
2018 Q1	$28.6K	Sell	302 -338	-53%	-$37.1K	0.02%	169
2017 Q4	$61.9K	Sell	640 -55	-8%	-$5.18K	0.05%	109
2017 Q3	$61.8K	Sell	695 -72	-9%	-$5.48K	0.05%	122
2017 Q2	$55.6K	Buy	767 +55	+8%	+$3.7K	0.05%	140
2017 Q1	$46.4K	Buy	712 +252	+55%	+$15.8K	0.04%	131
2016 Q4	$28.8K	Buy	460 +59	+15%	+$3.6K	0.02%	158
2016 Q3	$25.3K	Sell	401 -32	-7%	-$2.07K	0.02%	154
2016 Q2	$26.8K	Sell	433 -460	-52%	-$28K	0.01%	169
2016 Q1	$51K	Buy	+893	New	+$49.8K	0.04%	130

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RPg Family Wealth Advisory's ABBV Position: Q2 2022 in Review

RPg Family Wealth Advisory sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 134 shares — an estimated $21.7K sold.

RPg Family Wealth Advisory first reported a position in ABBV in Q1 2016 and held it in 17 quarters. The position peaked at $61.9K in Q4 2017. 3,004 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

RPg Family Wealth Advisory reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
RPg Family Wealth Advisory sold 134 AbbVie shares in Q2 2022, an estimated $21.7K.
RPg Family Wealth Advisory first reported a position in AbbVie in Q1 2016 and held it in 17 quarters.
RPg Family Wealth Advisory's AbbVie position peaked at $61.9K in Q4 2017.
3,004 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on RPg Family Wealth Advisory's 13F filing for Q2 2022, filed 12 Aug 2022.